The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Octanate 250 IU.Powder and solvent for solution for injection

Octapharma (IP) SPRLPA2219/004/001

Main Information

Trade NameOctanate 250 IU.Powder and solvent for solution for injection
Active SubstancesHuman plasmafraktion (factor viii)
Dosage FormPowder and solvent for solution for injection
Licence HolderOctapharma (IP) SPRL
Licence NumberPA2219/004/001

Group Information

ATC CodeB02BD Blood coagulation factors
B02BD02 coagulation factor VIII


License statusAuthorised
Licence Issued04/06/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back